සැකිල්ල:Infobox drug/testcases

Infobox drug/testcases
Legal status
Legal status	AU: S2 (Pharmacy medicine); BR: Class A1 (Narcotic drugs); CA: Schedule I; DE: Anlage I (Authorized scientific use only); UK: General sales list (GSL, OTC); US: ℞-only;

Infobox drug/testcases
Clinical data
Other names	synonyms
Biosimilars	rituximab-abbs, rituximab-pvvr, rituximab-arrx
AHFS/Drugs.com	Monograph

Infobox drug/testcases
Clinical data
Other names	synonyms
Biosimilars	rituximab-abbs, rituximab-pvvr, rituximab-arrx
AHFS/Drugs.com	Monograph

This is the template test cases page for the sandbox of සැකිල්ල:Infobox drug. Purge this page to update the examples.
If there are many examples of a complicated template, later ones may break due to limits in MediaWiki, see the HTML comment "NewPP limit report" in the rendered page.

You can also use Special:ExpandTemplates to examine the results of template uses.

You can test how this page looks in the different skins with these links:

v t e Infobox drug development (Drugbox - talk central, overview, sandboxes, testcases) WT:PHARM
`/sandbox:` {{Drugbox}} · e {{title}} · e · src {{licence}} · e · src {{legal}} · e · src {{pregcat}} · e · src {{molarmass}} · e · src {{mab source}} · e · src {{localINNvar}} · e · src {{maint cat}} · e · src {{fmtATC}} · e · src /format · Infobox drug (/sbox edit diff /test \| Source e Talk hist links # /subpages /doc) FDA-2023 {{Infobox drug/doc/FDA-2023}} · /testcases-FDA -- 2023 · /sandbox2 parameters Full parameter list (edit) · Type-conditional sections TPU cats:ප්‍රවර්ගය:Infobox drug tracking categories (7): ප්‍රවර්ගය:Pages using infobox drug with unknown parameters (1) · Parameter usage report cat:IBdrug templates · cat:Templates used in IBdrug testcases (m view): Template:Infobox drug/testcases -- General /testcases2 -- titles, licence, EMA /testcases3 -- pregcat, legal, licence, PLLR, ATC; Wikidata /testcases4 -- chem formula, mab /testcases5 -- identifiers, second id's /testcases6 -- all up /testcases7images -- images /testcases8 -- type, titles /testcases9 -- order variants, container_only /testcases10 -- pharmacokinetic, localINN (2017) has (data page) -- is a redirect /testcases11 -- hormone, gene therapy (2018), has (data page) /testcases-FDA -- FDA 2023 /testcases-warning -- warning box(es) RC recent changes Chem+Drugbox templates · Drugbox transclusions Module:TemplatePar bot Settings.css · Settings/sandbox · {{cascite}} chembox {{Chem/dev/nav}} · {{Chembox}} Infobox drug class (/sbox edit diff /test \| Source e Talk hist links # /subpages /doc) `විරේචනය`

biosimilars

eg Rituximab

Side by side comparison

References

^ "Truxima- rituximab-abbs injection, solution". DailyMed. සම්ප්‍රවේශය 26 March 2021.
^ "Ruxience- rituximab-pvvr injection, solution". DailyMed. සම්ප්‍රවේශය 26 March 2021.
^ "Riabni- rituximab-arrx injection, solution". DailyMed. සම්ප්‍රවේශය 26 March 2021.

Test Brazilian Legal Status

Side by side comparison

Infobox drug/testcases
Legal status
Legal status	AU: S2 (Pharmacy medicine) BR: Class A1 (Narcotic drugs) CA: Schedule I DE: Anlage I (Authorized scientific use only) UK: General sales list (GSL, OTC) US: ℞-only

Test 0 = blanks

Side by side comparison

Test 1

විරේචනය

Side by side comparison

Infobox drug/testcases
INN: Linezolid
Clinical data


Pronunciation	/njuːˈməʊniə/
Trade names	Linospan, Zyvox, Zyvoxam, Zyvoxid
Other names	Lenzomore
AHFS/Drugs.com	Monograph
MedlinePlus	a602004
License data	EU EMA: by INN US DailyMed: Linezolid US FDA: Linezolid
Pregnancy category	AU: C
Dependence liability	High
Addiction liability	Low
Routes of administration	Intravenous infusion, oral
ATC code	J01XX08 (WHO)
Pharmacokinetic data
Bioavailability	~100% (oral)
Protein binding	Low (31%)
Metabolism	Hepatic (50–70%, CYP not involved)
Metabolites	some stuff
Onset of action	1 hr
Elimination half-life	4.2–5.4 hours (shorter in children)
Duration of action	1 to 3 hr
Excretion	Nonrenal, renal, and fecal
Identifiers
IUPAC name (S)-N-({3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide
CAS Number	165800-03-3^Y[??]
PubChem CID	441401
IUPHAR/BPS	1234
DrugBank	DB00601
UNII	ISQ9I6J12J
KEGG	D00947^Y
ChEMBL	ChEMBL126^Y
NIAID ChemDB	070944
PDB ligand	ZLD (PDBe, RCSB PDB)
Chemical and physical data
Formula	C₁₆H₂₀FN₃O₄
Molar mass	337.346 g/mol
3D model (JSmol)	Interactive image
Density	1.40 g/cm³
Melting point	135 °C (275 °F)
Boiling point	140 °C (284 °F) (decomposes)
Solubility in water	3 mg/mL (20 °C)
SMILES O=C1O[C@@H](CNC(=O)C)CN1c3cc(F)c(N2CCOCC2)cc3
InChI InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1^Y Key:TYZROVQLWOKYKF-ZDUSSCGKSA-N^Y
^NY (what is this?) (verify)

Infobox drug/testcases
INN: Linezolid
Clinical data


Pronunciation	/njuːˈməʊniə/
Trade names	Linospan, Zyvox, Zyvoxam, Zyvoxid
Other names	Lenzomore
AHFS/Drugs.com	Monograph
MedlinePlus	a602004
License data	EU EMA: by INN US DailyMed: Linezolid US FDA: Linezolid
Pregnancy category	AU: C
Dependence liability	High
Addiction liability	Low
Routes of administration	Intravenous infusion, oral
ATC code	J01XX08 (WHO)
Pharmacokinetic data
Bioavailability	~100% (oral)
Protein binding	Low (31%)
Metabolism	Hepatic (50–70%, CYP not involved)
Metabolites	some stuff
Onset of action	1 hr
Elimination half-life	4.2–5.4 hours (shorter in children)
Duration of action	1 to 3 hr
Excretion	Nonrenal, renal, and fecal
Identifiers
IUPAC name (S)-N-({3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide
CAS Number	165800-03-3^Y[??]
PubChem CID	441401
IUPHAR/BPS	1234
DrugBank	DB00601
UNII	ISQ9I6J12J
KEGG	D00947^Y
ChEMBL	ChEMBL126^Y
NIAID ChemDB	070944
PDB ligand	ZLD (PDBe, RCSB PDB)
Chemical and physical data
Formula	C₁₆H₂₀FN₃O₄
Molar mass	337.346 g/mol
3D model (JSmol)	Interactive image
Density	1.40 g/cm³
Melting point	135 °C (275 °F)
Boiling point	140 °C (284 °F) (decomposes)
Solubility in water	3 mg/mL (20 °C)
SMILES O=C1O[C@@H](CNC(=O)C)CN1c3cc(F)c(N2CCOCC2)cc3
InChI InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1^Y Key:TYZROVQLWOKYKF-ZDUSSCGKSA-N^Y
^NY (what is this?) (verify)

විරේචනය

Test 2

Side by side comparison

Infobox drug/testcases
Clinical data

Pronunciation	/njuːˈməʊniə/
Other names	3{[(4-cyclopentyl-1-piperazinyl)imino]methyl}rifamycin
AHFS/Drugs.com	Monograph
MedlinePlus	a602026
ATC code	J04AB05 (WHO)
Pharmacokinetic data
Bioavailability	increases when administered with food
Onset of action	1 hr
Identifiers
IUPAC name (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z,26E)-26-{[(4-cyclopentylpiperazin-1-yl)amino]methylidene}-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1^4,7.0^5,28]triaconta-1(28),2,4,9,19,21,25(29)-heptaen-13-yl acetate
CAS Number	61379-65-5
PubChem CID	5462354
DrugBank	APRD01217
ChemSpider	10482075^Y
UNII	XJM390A33U
KEGG	D00879^N
ChEBI	CHEBI:45304^N
ChEMBL	ChEMBL1660^N
NIAID ChemDB	007686
Chemical and physical data
Formula	C₄₇H₆₄N₄O₁₂
Molar mass	877.031 g/mol
3D model (JSmol)	Interactive image
SMILES CC(=O)O[C@H]3[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(\C)C(=O)Nc6c(/C=N/N1CCN(CC1)C2CCCC2)c(O)c5c4C(=O)[C@@](C)(O/C=C/[C@H](OC)[C@H]3C)Oc4c(C)c(O)c5c6O
InChI InChI=1S/C47H64N4O12/c1-24-13-12-14-25(2)46(59)49-37-32(23-48-51-20-18-50(19-21-51)31-15-10-11-16-31)41(56)34-35(42(37)57)40(55)29(6)44-36(34)45(58)47(8,63-44)61-22-17-33(60-9)26(3)43(62-30(7)52)28(5)39(54)27(4)38(24)53/h12-14,17,22-24,26-28,31,33,38-39,43,53-57H,10-11,15-16,18-21H2,1-9H3,(H,49,59)/b13-12+,22-17+,25-14-,48-23+/t24-,26+,27+,28+,33-,38-,39+,43+,47-/m0/s1^Y Commenting here^[1] Key:WDZCUPBHRAEYDL-GZAUEHORSA-N^Y
^NY (what is this?) (verify)

Infobox drug/testcases
Clinical data

Pronunciation	/njuːˈməʊniə/
Other names	3{[(4-cyclopentyl-1-piperazinyl)imino]methyl}rifamycin
AHFS/Drugs.com	Monograph
MedlinePlus	a602026
ATC code	J04AB05 (WHO)
Pharmacokinetic data
Bioavailability	increases when administered with food
Onset of action	1 hr
Identifiers
IUPAC name (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z,26E)-26-{[(4-cyclopentylpiperazin-1-yl)amino]methylidene}-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1^4,7.0^5,28]triaconta-1(28),2,4,9,19,21,25(29)-heptaen-13-yl acetate
CAS Number	61379-65-5
PubChem CID	5462354
DrugBank	APRD01217
ChemSpider	10482075^Y
UNII	XJM390A33U
KEGG	D00879^N
ChEBI	CHEBI:45304^N
ChEMBL	ChEMBL1660^N
NIAID ChemDB	007686
Chemical and physical data
Formula	C₄₇H₆₄N₄O₁₂
Molar mass	877.031 g/mol
3D model (JSmol)	Interactive image
SMILES CC(=O)O[C@H]3[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(\C)C(=O)Nc6c(/C=N/N1CCN(CC1)C2CCCC2)c(O)c5c4C(=O)[C@@](C)(O/C=C/[C@H](OC)[C@H]3C)Oc4c(C)c(O)c5c6O
InChI InChI=1S/C47H64N4O12/c1-24-13-12-14-25(2)46(59)49-37-32(23-48-51-20-18-50(19-21-51)31-15-10-11-16-31)41(56)34-35(42(37)57)40(55)29(6)44-36(34)45(58)47(8,63-44)61-22-17-33(60-9)26(3)43(62-30(7)52)28(5)39(54)27(4)38(24)53/h12-14,17,22-24,26-28,31,33,38-39,43,53-57H,10-11,15-16,18-21H2,1-9H3,(H,49,59)/b13-12+,22-17+,25-14-,48-23+/t24-,26+,27+,28+,33-,38-,39+,43+,47-/m0/s1^Y Commenting here^[1] Key:WDZCUPBHRAEYDL-GZAUEHORSA-N^Y
^NY (what is this?) (verify)

References

^ Hello world

Test 3

Side by side comparison

Infobox drug/testcases
Vaccine description
Target	Tuberculosis
Vaccine type	Live bacteria
Clinical data
Pronunciation	/njuːˈməʊniə/
AHFS/Drugs.com	FDA Professional Drug Information
Routes of administration	Percutaneous
ATC code	J07AN01 (WHO)
Legal status
Legal status	US: ℞-only
Identifiers
ChemSpider	NA

Infobox drug/testcases
Vaccine description
Target	Tuberculosis
Vaccine type	Live bacteria
Clinical data
Pronunciation	/njuːˈməʊniə/
AHFS/Drugs.com	FDA Professional Drug Information
Routes of administration	Percutaneous
ATC code	J07AN01 (WHO)
Legal status
Legal status	US: ℞-only
Identifiers
ChemSpider	NA

Test 4

Side by side comparison

Infobox drug/testcases
Clinical data


Pronunciation	/njuːˈməʊniə/
Trade names	Lipitor, Atorva
AHFS/Drugs.com	Monograph
MedlinePlus	a600045
License data	US DailyMed: 42465 US FDA: Atorvastatin
Pregnancy category	AU: D
Routes of administration	Oral
ATC code	C10AA05 (WHO)
Legal status
Legal status	AU: S4 (Prescription only) UK: POM (Prescription only) US: ℞-only
Pharmacokinetic data
Bioavailability	12%
Metabolism	Hepatic - CYP3A4
Onset of action	1 hr
Elimination half-life	14 h
Excretion	Bile
Identifiers
IUPAC name (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid
CAS Number	134523-00-5^Y[??]
PubChem CID	60823
IUPHAR/BPS	2949
DrugBank	APRD00055සැකිල්ල:Drugbankcite
ChemSpider	54810^Y
UNII	A0JWA85V8F
KEGG	D07474^Y
ChEBI	CHEBI:39548^Y
ChEMBL	ChEMBL1487^Y
PDB ligand	117 (PDBe, RCSB PDB)
Chemical and physical data
Formula	C₃₃H₃₅Ca₂FN₂O₅
Molar mass	558.64
3D model (JSmol)	Interactive image
SMILES O=C(O)C[C@H](O)C[C@H](O)CCn2c(c(c(c2c1ccc(F)cc1)c3ccccc3)C(=O)Nc4ccccc4)C(C)C
InChI InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1^Y Key:XUKUURHRXDUEBC-KAYWLYCHSA-N^Y
^NY (what is this?) (verify)

Infobox drug/testcases
Clinical data


Pronunciation	/njuːˈməʊniə/
Trade names	Lipitor, Atorva
AHFS/Drugs.com	Monograph
MedlinePlus	a600045
License data	US DailyMed: 42465 US FDA: Atorvastatin
Pregnancy category	AU: D
Routes of administration	Oral
ATC code	C10AA05 (WHO)
Legal status
Legal status	AU: S4 (Prescription only) UK: POM (Prescription only) US: ℞-only
Pharmacokinetic data
Bioavailability	12%
Metabolism	Hepatic - CYP3A4
Onset of action	1 hr
Elimination half-life	14 h
Excretion	Bile
Identifiers
IUPAC name (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid
CAS Number	134523-00-5^Y[??]
PubChem CID	60823
IUPHAR/BPS	2949
DrugBank	APRD00055සැකිල්ල:Drugbankcite
ChemSpider	54810^Y
UNII	A0JWA85V8F
KEGG	D07474^Y
ChEBI	CHEBI:39548^Y
ChEMBL	ChEMBL1487^Y
PDB ligand	117 (PDBe, RCSB PDB)
Chemical and physical data
Formula	C₃₃H₃₅Ca₂FN₂O₅
Molar mass	558.64
3D model (JSmol)	Interactive image
SMILES O=C(O)C[C@H](O)C[C@H](O)CCn2c(c(c(c2c1ccc(F)cc1)c3ccccc3)C(=O)Nc4ccccc4)C(C)C
InChI InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1^Y Key:XUKUURHRXDUEBC-KAYWLYCHSA-N^Y
^NY (what is this?) (verify)

Test all 1

Side by side comparison

1
Clinical data

some images
Pronunciation	/njuːˈməʊniə/
Trade names	25
Other names	72
AHFS/Drugs.com	27
MedlinePlus	29
License data	EU EMA: by INN US DailyMed: 32 US FDA: 31
Pregnancy category	AU: B3 35
Dependence liability	43
Routes of administration	44
ATC code	5455 (WHO) 56
Legal status
Legal status	AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability	45
Protein binding	46
Metabolism	47
Onset of action	47.5
Elimination half-life	48
Excretion	49
Identifiers
IUPAC name 12
CAS Number	5051 52
PubChem CID	57
PubChem SID	58
IUPHAR/BPS	59
DrugBank	60
ChemSpider	6162
UNII	63
KEGG	6566
ChEBI	CHEBI:6768
ChEMBL	ChEMBL6970
NIAID ChemDB	71
PDB ligand	73 (PDBe, RCSB PDB)
Chemical and physical data
Formula	74
Molar mass	75
3D model (JSmol)	Interactive image
Specific rotation	90
Density	83 g/cm³ note83
Melting point	84 to 85 °C (183 to 185 °F) 86
Boiling point	87 °C (189 °F) 88
Solubility in water	89 mg/mL (20 °C)
SMILES 76
InChI InChI=7779 78 Key:8082
(verify)

1
Clinical data

some images
Pronunciation	/njuːˈməʊniə/
Trade names	25
Other names	72
AHFS/Drugs.com	27
MedlinePlus	29
License data	EU EMA: by INN US DailyMed: 32 US FDA: 31
Pregnancy category	AU: B3 35
Dependence liability	43
Routes of administration	44
ATC code	5455 (WHO) 56
Legal status
Legal status	AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability	45
Protein binding	46
Metabolism	47
Onset of action	47.5
Elimination half-life	48
Excretion	49
Identifiers
IUPAC name 12
CAS Number	5051 52
PubChem CID	57
PubChem SID	58
IUPHAR/BPS	59
DrugBank	60
ChemSpider	6162
UNII	63
KEGG	6566
ChEBI	CHEBI:6768
ChEMBL	ChEMBL6970
NIAID ChemDB	71
PDB ligand	73 (PDBe, RCSB PDB)
Chemical and physical data
Formula	74
Molar mass	75
3D model (JSmol)	Interactive image
Specific rotation	90
Density	83 g/cm³ note83
Melting point	84 to 85 °C (183 to 185 °F) 86
Boiling point	87 °C (189 °F) 88
Solubility in water	89 mg/mL (20 °C)
SMILES 76
InChI InChI=7779 78 Key:8082
(verify)

Test all 2

Side by side comparison

1
Combination of

some images
17	18
19	20
21	22
23	24
Clinical data
Pronunciation	/njuːˈməʊniə/
Trade names	25
Other names	72
AHFS/Drugs.com	27
MedlinePlus	29
License data	EU EMA: by INN US DailyMed: 32 US FDA: 31
Pregnancy category	AU: B3 35
Dependence liability	43
Routes of administration	44
ATC code	5455 (WHO) 56
Legal status
Legal status	AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability	45
Protein binding	46
Metabolism	47
Onset of action	47.5
Elimination half-life	48
Excretion	49
Identifiers
CAS Number	5051 52
PubChem CID	57
PubChem SID	58
IUPHAR/BPS	59
DrugBank	60
ChemSpider	6162
UNII	63
KEGG	6566
ChEBI	CHEBI:6768
ChEMBL	ChEMBL6970
NIAID ChemDB	71
Chemical and physical data
Formula	74
Molar mass	75
3D model (JSmol)	Interactive image
Specific rotation	90
Density	83 g/cm³
Melting point	84 to 85 °C (183 to 185 °F) 86
Boiling point	87 °C (189 °F) 88
Solubility in water	89 mg/mL (20 °C)
SMILES 76
InChI InChI=7779 78 Key:8082
(verify)

1
Combination of

some images
17	18
19	20
21	22
23	24
Clinical data
Pronunciation	/njuːˈməʊniə/
Trade names	25
Other names	72
AHFS/Drugs.com	27
MedlinePlus	29
License data	EU EMA: by INN US DailyMed: 32 US FDA: 31
Pregnancy category	AU: B3 35
Dependence liability	43
Routes of administration	44
ATC code	5455 (WHO) 56
Legal status
Legal status	AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability	45
Protein binding	46
Metabolism	47
Onset of action	47.5
Elimination half-life	48
Excretion	49
Identifiers
CAS Number	5051 52
PubChem CID	57
PubChem SID	58
IUPHAR/BPS	59
DrugBank	60
ChemSpider	6162
UNII	63
KEGG	6566
ChEBI	CHEBI:6768
ChEMBL	ChEMBL6970
NIAID ChemDB	71
Chemical and physical data
Formula	74
Molar mass	75
3D model (JSmol)	Interactive image
Specific rotation	90
Density	83 g/cm³
Melting point	84 to 85 °C (183 to 185 °F) 86
Boiling point	87 °C (189 °F) 88
Solubility in water	89 mg/mL (20 °C)
SMILES 76
InChI InChI=7779 78 Key:8082
(verify)

Test all 3

Side by side comparison

1
Vaccine description

some images
Target	13
Vaccine type	Toxoid
Clinical data
Pronunciation	/njuːˈməʊniə/
Trade names	25
Other names	72
AHFS/Drugs.com	27
MedlinePlus	29
License data	EU EMA: by INN US DailyMed: 32 US FDA: 31
Pregnancy category	AU: B3 35
Dependence liability	43
Routes of administration	44
ATC code	5455 (WHO) 56
Legal status
Legal status	AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability	45
Protein binding	46
Metabolism	47
Onset of action	47.5
Elimination half-life	48
Excretion	49
Identifiers
CAS Number	5051 52
PubChem CID	57
PubChem SID	58
IUPHAR/BPS	59
DrugBank	60
ChemSpider	6162
UNII	63
KEGG	6566
ChEBI	CHEBI:6768
ChEMBL	ChEMBL6970
NIAID ChemDB	71
Chemical and physical data
Formula	74
Molar mass	75
3D model (JSmol)	Interactive image
Specific rotation	90
Density	83 g/cm³
Melting point	84 to 85 °C (183 to 185 °F) 86
Boiling point	87 °C (189 °F) 88
Solubility in water	89 mg/mL (20 °C)
SMILES 76
InChI InChI=7779 78 Key:8082
(verify)

1
Vaccine description

some images
Target	13
Vaccine type	Toxoid
Clinical data
Pronunciation	/njuːˈməʊniə/
Trade names	25
Other names	72
AHFS/Drugs.com	27
MedlinePlus	29
License data	EU EMA: by INN US DailyMed: 32 US FDA: 31
Pregnancy category	AU: B3 35
Dependence liability	43
Routes of administration	44
ATC code	5455 (WHO) 56
Legal status
Legal status	AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability	45
Protein binding	46
Metabolism	47
Onset of action	47.5
Elimination half-life	48
Excretion	49
Identifiers
CAS Number	5051 52
PubChem CID	57
PubChem SID	58
IUPHAR/BPS	59
DrugBank	60
ChemSpider	6162
UNII	63
KEGG	6566
ChEBI	CHEBI:6768
ChEMBL	ChEMBL6970
NIAID ChemDB	71
Chemical and physical data
Formula	74
Molar mass	75
3D model (JSmol)	Interactive image
Specific rotation	90
Density	83 g/cm³
Melting point	84 to 85 °C (183 to 185 °F) 86
Boiling point	87 °C (189 °F) 88
Solubility in water	89 mg/mL (20 °C)
SMILES 76
InChI InChI=7779 78 Key:8082
(verify)

Test all 4

Side by side comparison

1
Monoclonal antibody

some images
Type	F(ab')₂ fragment
Source	Chimeric (rat/human)
Target	13
Clinical data
Pronunciation	/njuːˈməʊniə/
Trade names	25
Other names	72
AHFS/Drugs.com	27
MedlinePlus	29
License data	EU EMA: by INN US DailyMed: 32 US FDA: 31
Pregnancy category	AU: B3 35
Dependence liability	43
Addiction liability	43b
Routes of administration	44
ATC code	5455 (WHO) 56
Legal status
Legal status	AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability	45
Protein binding	46
Metabolism	47
Onset of action	47.5
Elimination half-life	48
Excretion	49
Identifiers
CAS Number	5051 52
PubChem CID	57
PubChem SID	58
IUPHAR/BPS	59
DrugBank	60
ChemSpider	6162
UNII	63
KEGG	6566
ChEBI	CHEBI:6768
ChEMBL	ChEMBL6970
NIAID ChemDB	71
PDB ligand	73 (PDBe, RCSB PDB)
Chemical and physical data
Formula	74
Molar mass	75
3D model (JSmol)	Interactive image
Specific rotation	90
Density	83 g/cm³
Melting point	84 to 85 °C (183 to 185 °F) 86
Boiling point	87 °C (189 °F) 88
Solubility in water	89 mg/mL (20 °C)
SMILES 76
InChI InChI=7779 78 Key:8082
(verify)

1
Monoclonal antibody

some images
Type	F(ab')₂ fragment
Source	Chimeric (rat/human)
Target	13
Clinical data
Pronunciation	/njuːˈməʊniə/
Trade names	25
Other names	72
AHFS/Drugs.com	27
MedlinePlus	29
License data	EU EMA: by INN US DailyMed: 32 US FDA: 31
Pregnancy category	AU: B3 35
Dependence liability	43
Addiction liability	43b
Routes of administration	44
ATC code	5455 (WHO) 56
Legal status
Legal status	AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability	45
Protein binding	46
Metabolism	47
Onset of action	47.5
Elimination half-life	48
Excretion	49
Identifiers
CAS Number	5051 52
PubChem CID	57
PubChem SID	58
IUPHAR/BPS	59
DrugBank	60
ChemSpider	6162
UNII	63
KEGG	6566
ChEBI	CHEBI:6768
ChEMBL	ChEMBL6970
NIAID ChemDB	71
PDB ligand	73 (PDBe, RCSB PDB)
Chemical and physical data
Formula	74
Molar mass	75
3D model (JSmol)	Interactive image
Specific rotation	90
Density	83 g/cm³
Melting point	84 to 85 °C (183 to 185 °F) 86
Boiling point	87 °C (189 °F) 88
Solubility in water	89 mg/mL (20 °C)
SMILES 76
InChI InChI=7779 78 Key:8082
(verify)

Test formula 1

Side by side comparison

1
Clinical data

some images
Pronunciation	/njuːˈməʊniə/
Trade names	25
Other names	72
AHFS/Drugs.com	27
MedlinePlus	29
License data	EU EMA: by INN US DailyMed: 32 US FDA: 31
Pregnancy category	AU: B3 35
Dependence liability	43
Routes of administration	44
ATC code	5455 (WHO) 56
Legal status
Legal status	AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability	45
Protein binding	46
Metabolism	47
Onset of action	47.5
Elimination half-life	48
Excretion	49
Identifiers
IUPAC name 12
CAS Number	5051 52
PubChem CID	57
PubChem SID	58
IUPHAR/BPS	59
DrugBank	60
ChemSpider	6162
UNII	63
KEGG	6566
ChEBI	CHEBI:6768
ChEMBL	ChEMBL6970
NIAID ChemDB	71
PDB ligand	73 (PDBe, RCSB PDB)
Chemical and physical data
Formula	CH₂Ag₃Al₄As₅Au₆B₇Bi₈⁻¹
Molar mass	75
3D model (JSmol)	Interactive image
Specific rotation	90
Density	83 g/cm³
Melting point	84 to 85 °C (183 to 185 °F) 86
Boiling point	87 °C (189 °F) 88
Solubility in water	89 mg/mL (20 °C)
SMILES 76
InChI InChI=7779 78 Key:8082
(verify)

1
Clinical data

some images
Pronunciation	/njuːˈməʊniə/
Trade names	25
Other names	72
AHFS/Drugs.com	27
MedlinePlus	29
License data	EU EMA: by INN US DailyMed: 32 US FDA: 31
Pregnancy category	AU: B3 35
Dependence liability	43
Routes of administration	44
ATC code	5455 (WHO) 56
Legal status
Legal status	AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability	45
Protein binding	46
Metabolism	47
Onset of action	47.5
Elimination half-life	48
Excretion	49
Identifiers
IUPAC name 12
CAS Number	5051 52
PubChem CID	57
PubChem SID	58
IUPHAR/BPS	59
DrugBank	60
ChemSpider	6162
UNII	63
KEGG	6566
ChEBI	CHEBI:6768
ChEMBL	ChEMBL6970
NIAID ChemDB	71
PDB ligand	73 (PDBe, RCSB PDB)
Chemical and physical data
Formula	CH₂Ag₃Al₄As₅Au₆B₇Bi₈⁻¹
Molar mass	75
3D model (JSmol)	Interactive image
Specific rotation	90
Density	83 g/cm³
Melting point	84 to 85 °C (183 to 185 °F) 86
Boiling point	87 °C (189 °F) 88
Solubility in water	89 mg/mL (20 °C)
SMILES 76
InChI InChI=7779 78 Key:8082
(verify)

Test formula 2

Side by side comparison

1
Clinical data

some images
Pronunciation	/njuːˈməʊniə/
Trade names	25
Other names	72
AHFS/Drugs.com	27
MedlinePlus	29
License data	EU EMA: by INN US DailyMed: 32 US FDA: 31
Pregnancy category	AU: B3 35
Dependence liability	43
Routes of administration	44
ATC code	5455 (WHO) 56
Legal status
Legal status	AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability	45
Protein binding	46
Metabolism	47
Onset of action	47.5
Elimination half-life	48
Excretion	49
Identifiers
IUPAC name 12
CAS Number	5051 52
PubChem CID	57
PubChem SID	58
IUPHAR/BPS	59
DrugBank	60
ChemSpider	6162
UNII	63
KEGG	6566
ChEBI	CHEBI:6768
ChEMBL	ChEMBL6970
NIAID ChemDB	71
PDB ligand	73 (PDBe, RCSB PDB)
Chemical and physical data
Formula	CBr₉Ca₁₀Cl₁₁Co₁₂Cr₁₃F₁₄Fe₁₅Gd₁₆Hg₁₇⁻¹
Molar mass	75
3D model (JSmol)	Interactive image
Specific rotation	90
Density	note83
Melting point	84 to 85 °C (183 to 185 °F) 86
Boiling point	87 °C (189 °F) 88
Solubility in water	89 mg/mL (20 °C)
SMILES 76
InChI InChI=7779 78 Key:8082
(verify)

1
Clinical data

some images
Pronunciation	/njuːˈməʊniə/
Trade names	25
Other names	72
AHFS/Drugs.com	27
MedlinePlus	29
License data	EU EMA: by INN US DailyMed: 32 US FDA: 31
Pregnancy category	AU: B3 35
Dependence liability	43
Routes of administration	44
ATC code	5455 (WHO) 56
Legal status
Legal status	AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability	45
Protein binding	46
Metabolism	47
Onset of action	47.5
Elimination half-life	48
Excretion	49
Identifiers
IUPAC name 12
CAS Number	5051 52
PubChem CID	57
PubChem SID	58
IUPHAR/BPS	59
DrugBank	60
ChemSpider	6162
UNII	63
KEGG	6566
ChEBI	CHEBI:6768
ChEMBL	ChEMBL6970
NIAID ChemDB	71
PDB ligand	73 (PDBe, RCSB PDB)
Chemical and physical data
Formula	CBr₉Ca₁₀Cl₁₁Co₁₂Cr₁₃F₁₄Fe₁₅Gd₁₆Hg₁₇⁻¹
Molar mass	75
3D model (JSmol)	Interactive image
Specific rotation	90
Density	note83
Melting point	84 to 85 °C (183 to 185 °F) 86
Boiling point	87 °C (189 °F) 88
Solubility in water	89 mg/mL (20 °C)
SMILES 76
InChI InChI=7779 78 Key:8082
(verify)

Test formula 3

Side by side comparison

1
Clinical data

some images
Pronunciation	/njuːˈməʊniə/
Trade names	25
Other names	72
AHFS/Drugs.com	27
MedlinePlus	29
License data	EU EMA: by INN US DailyMed: 32 US FDA: 31
Pregnancy category	AU: B3 35
Dependence liability	43
Routes of administration	44
ATC code	5455 (WHO) 56
Legal status
Legal status	AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability	45
Protein binding	46
Metabolism	47
Onset of action	47.5
Elimination half-life	48
Excretion	49
Identifiers
IUPAC name 12
CAS Number	5051 52
PubChem CID	57
PubChem SID	58
IUPHAR/BPS	59
DrugBank	60
ChemSpider	6162
UNII	63
KEGG	6566
ChEBI	CHEBI:6768
ChEMBL	ChEMBL6970
NIAID ChemDB	71
PDB ligand	73 (PDBe, RCSB PDB)
Chemical and physical data
Formula	I₁₈K₁₉Li₂₀Mg₂₁Mn₂₂N₂₃Na₂₄O₂₅P₂₆Pt₂₇⁻¹
Molar mass	75
3D model (JSmol)	Interactive image
Specific rotation	90
Density	83 g/cm³
Melting point	84 to 85 °C (183 to 185 °F) 86
Boiling point	87 °C (189 °F) 88
Solubility in water	89 mg/mL (20 °C)
SMILES 76
InChI InChI=7779 78 Key:8082
(verify)

1
Clinical data

some images
Pronunciation	/njuːˈməʊniə/
Trade names	25
Other names	72
AHFS/Drugs.com	27
MedlinePlus	29
License data	EU EMA: by INN US DailyMed: 32 US FDA: 31
Pregnancy category	AU: B3 35
Dependence liability	43
Routes of administration	44
ATC code	5455 (WHO) 56
Legal status
Legal status	AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability	45
Protein binding	46
Metabolism	47
Onset of action	47.5
Elimination half-life	48
Excretion	49
Identifiers
IUPAC name 12
CAS Number	5051 52
PubChem CID	57
PubChem SID	58
IUPHAR/BPS	59
DrugBank	60
ChemSpider	6162
UNII	63
KEGG	6566
ChEBI	CHEBI:6768
ChEMBL	ChEMBL6970
NIAID ChemDB	71
PDB ligand	73 (PDBe, RCSB PDB)
Chemical and physical data
Formula	I₁₈K₁₉Li₂₀Mg₂₁Mn₂₂N₂₃Na₂₄O₂₅P₂₆Pt₂₇⁻¹
Molar mass	75
3D model (JSmol)	Interactive image
Specific rotation	90
Density	83 g/cm³
Melting point	84 to 85 °C (183 to 185 °F) 86
Boiling point	87 °C (189 °F) 88
Solubility in water	89 mg/mL (20 °C)
SMILES 76
InChI InChI=7779 78 Key:8082
(verify)

Test formula 4

සැකිල්ල:Testcase table

[Truxima_FDA_label-1] "Truxima- rituximab-abbs injection, solution". DailyMed. සම්ප්‍රවේශය 26 March 2021.

[Ruxience_FDA_label-2] "Ruxience- rituximab-pvvr injection, solution". DailyMed. සම්ප්‍රවේශය 26 March 2021.

[Riabni_FDA_label-3] "Riabni- rituximab-arrx injection, solution". DailyMed. සම්ප්‍රවේශය 26 March 2021.

[4] Hello world

[1]

[2]

[3]

[1]